Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5-1 - ATOSSA THERAPEUTICS, INC. | s110620_ex5-1.htm |
| S-1 - FORM S-1 - ATOSSA THERAPEUTICS, INC. | s110620_s-1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Atossa Genetics Inc.
Seattle, Washington
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-1 of our report dated March 8, 2018, relating to the consolidated financial statements of Atossa Genetics Inc. (the “Company”), appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ BDO USA, LLP
Seattle, Washington
June 4, 2018